Modules | Vaccine

On-demand webinar: RSV in older adults: understanding risk and preventative measures

EA hours: 1
MO hours:
RP hours:
Total hours: 1
Image
On this page

    This on-demand webinar, presented by A/Prof Michael Woodward, Prof Grant Waterer and Dr Victoria Hayes will equip GPs to understand the prevalence, seasonal patterns, and demographic impacts of RSV in Australia. It also outlines preventative measures in older age groups, including safety and efficacy features of the new RSV vaccine for adults.

     

    This on-demand webinar is part of a series on RSV, other activities include:

     

    Presented by A/Prof Michael Woodward, Prof Grant Waterer and Dr Victoria Hayes

     

     

     

     

     

     

    Associate Professor Michael Woodward AM MBBS MD FRACP

    Associate Professor Michael Woodward is Head of Dementia Research at Austin Health in Melbourne, Victoria. He is a specialist in geriatric medicine with a major interest in adult vaccination and also Alzheimer’s disease and other dementias, wound management and the quality use of medications in older people. The Medical and Cognitive Research Unit that he established conducts trials into new vaccines and other new therapies for conditions such as dementia and influenza.

     

     

     

     

    Professor Grant Waterer MBBS PhD MBA FRACP FCCP

    Dr Waterer is Professor of Medicine at the University of Western Australia, Adjunct Professor of Medicine at Northwestern University, Chicago and Curtin University, Perth and Adjunct Professor at Edith Cowan University. He is the Executive Director of Medical Services for East Metropolitan Health Service. His main research interests are in pulmonary infections, especially pneumonia and non-tuberculous mycobacterial disease, as well as bronchiectasis, COPD and of course COVID-19.


     

     

     

     

     

     

     

    Dr Victoria Hayes MBBS FRACGP

    Dr Hayes is a GP with interests in immunisation, women and children’s health and preventative medicine. She is part of Asprey network. When she is not working she enjoys travel and her community choir.

    Learning outcomes

    On completion of this educational activity participants will be able to:
    Explain the risk of respiratory syncytial virus (RSV) in people aged 60 and above and how the risk is influenced by advancing age and common chronic conditions.
    Outline complications of RSV in older patients.
    Recommend non-medical measures to prevent RSV transmission among older adults.
    Educate patients about the availability of an RSV vaccine in Australia, and outline its efficacy and potential side effects.

    On-demand webinar: RSV in older adults: understanding risk and preventative measures - Education
    On-demand webinar: RSV in older adults: understanding risk and preventative measures - Evaluation
    Sponsored by

    GSK

    RACGP and ACRRM CPD logo